1. Authors' response to Walker et al. Issue 4 (14th October 2013) Authors: Tashkin, D P; Metzdorf, N; Hallmann, C; Leimer, I; Lee, T; Decramer, M Journal: Thorax Issue: Volume 69:Issue 4(2014) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P259 Tiotropium Handihaler® And Respimat® In Copd: A Safety Analysis On Pooled Data. (10th November 2014) Authors: Halpin, DMG; Dahl, R; Hallmann, C; Leimer, I; Mueller, A; Tashkin, DP Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P294 Benefits of tiotropium/olodaterol over tiotropium at delaying clinically significant events in patients with copd classified as gold B. (15th November 2016) Authors: Buhl, R; McGarvey, L; Korn, S; Ferguson, GT; Grönke, L; Hallmann, C; Voß, F; Rabe, KF; Maltais, F Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S108 Effect of baseline FVC on decline in lung function with nintedanib in patients with IPF: results from the INPULSIS® trials. (12th November 2015) Authors: Kolb, M; Kimura, T; Stowasser, S; Hallmann, C; Richeldi, L Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S110 Efficacy and safety of nintedanib in patients with IPF beyond week 52: Data from the Phase II TOMORROW trial. (12th November 2015) Authors: Richeldi, L; Costabel, U; Selman, M; Xu, Z; Kimura, T; Stowasser, S; Hallmann, C Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗